Further work since then suggests that serum yglutamyltransferase activity may be a sensitive index of hepatobiliary dysfunction,3 and the early prediction that measurement of y-glutamyltransferase activity would be established in the laboratory repertoire seems to have been fulfilled. 4 The association between excessive alcohol consumption and raised activities of serum -,'-glutamyltransferase, particularly in the absence of other abnormal results of biochemical tests of liver function, was made in the early 1970s, and a serum y-glutamyltransferase estimation has been included in many screening programmes to detect an excessive intake of alcohol.5 6 It is rare, however, to find a biochemical test that is both tissue specific and disease specific, and y-glutamyltransferase activity appears to be no exception. The serum activity of the enzyme has been shown to be affected by several factors and to rise in various clinical conditions. Also its induction by a wide variety of drugs, including alcohol, makes interpretation of test results difficult. Consequently, the claimed advantage of its sensitivity is marred by its lack of specificity. Recently, doubts have even been expressed about the clinical value of serum y-glutamyltransferase activities in the diagnosis of hepatobiliary disease7 and also about the dangers of misinterpreting raised activities found in screening healthy subjects or hospital patients.8-'0 We believe that serum y-glutamyltransferase activity is estimated too often, and that clinical and laboratory staff should be much more critical about the need for assaying this enzyme.
Location, role, and structure of y-glutamyltransferase
The tissue and intracellular distributions of y-glutamyltransferase are well established and widely documented."-"' Histochemical techniques have shown that the enzyme is present in cell membranes of many tissues, especially those concerned in secretory or absorptive processes, such as the brush border of the kidney and the bile canaliculi. The precise physiological function of y-glutamyltransferase, which is a glycoprotein, remains to be clarified, though it is generally accepted that the enzyme facilitates amino acid tra-nsport across cell membranes and is concerned in glutathione metabolism.'5 High concentrations are found in the kidney and pancreas with a relatively low concentration (but large total quantity) in the liver. '6 17 Nevertheless, the results of kinetic and electrophoretic studies indicate that the enzyme found in serum of normal subjects originates from the liver.'8 Physicochemical differences are conferred on the enzyme by different carbohydrate moieties, and this property has led to the separation of several forms of the enzyme. '9 Reference ranges and physiological factors affecting y-glutamyltransferase 25 In a pregnant patient with suspected liver disease and a raised alkaline phosphatase value, the estimation of serum y-glutamyltransferase activity may be useful in differentiating between the hepatic and placental alkaline phosphatase isoenzymes. Raised alkaline phosphatase values in pregnancy are difficult to interpret since the placenta contributes to the circulatory level, but if hepatocellular disease is suspected an assay of serum transaminase activities should be the first line of investigation. If these are normal then characterisation of the alkaline phosphatase isoenzymes is probably a more reliable diagnostic procedure than estimation of serum y-glutamyltransferase activity.
Liver disease and y-glutamyltransferase
In most liver diseases y-glutamyltransferase activity is a sensitive, but non-specific, indicator of primary liver disease, its activity being above the reference interval in roughly 90% of such cases.3 When various categories of hepatobiliary diseases, including alcoholic liver disease, are grouped together, the sensitivity of the estimation is variously reported to be between 87% and 95%.7 2629 Compared with other standard tests of liver function the serum y-glutamyltransferase activity may be the most sensitive indicator of liver disease, but since it rises in virtually all types of liver disease the test is of little value in the differential diagnosis of hepatobiliary disease.'0 Various studies have compared y-glutamyltransferase with other tests of liver function-for instance, serum alkaline phosphatase, 5'-nucleotidase, bilirubin, and transaminases activities-in an attempt to define the most clinically useful tests or combination of tests for differential diagnosis." 32 Estimation of y-glutamyltransferase shows little or no benefit over the more traditional biochemical tests for differential diagnosis in liver disease. Although y-glutamyltransferase activity may be raised in many cases of liver disease, the magnitude of the increase tends to be variable. The highest levels of y-glutamyltransferase activity are found in cases of biliary obstruction, carcinoma metastatic to the liver, cirrhosis, and chronic alcoholism; but enzyme induction due to drugs and alcohol makes it difficult to rely on an isolated raised result as indicating liver disease.
HEPATITIS
The diagnostic value of serum y-glutamyltransferase estimations in acute hepatitis is doubtful and transaminase estimations have proved superior, both as a more sensitive marker of liver cell damage and as a better guide to the progression of the disease." The clinical picture and the very high serum transaminase activities are so characteristic in most cases of acute hepatitis that y-glutamyltransferase estimations are unnecessary. y-Glutamyltransferase activities tend to rise and return to normal later in the disease than the transaminases, and the estimation may therefore be of some use in monitoring the progress from acute to chronic hepatitis, when values remain high. The aspartate or alanine transaminase/y-glutamyltransferase ratio is useful in differentiating acute hepatitis from extrahepatic cholestasis,34 with a high ratio in acute hepatitis owing to the disproportionately high transaminase activities seen. Nevertheless, the ratio may not discriminate completely between viral hepatitis and intrahepatic cholestasis, since the activities of y-glutamyltransferase in intrahepatic cholestasis are generally lower than in extrahepatic cholestasis, and therefore interpretations must be made with caution.35 Moreover, alkaline phosphatase activity has long been used in this way with varying success and y-glutamyltransferase activity seems no more discriminatory. Alcoholism and y-glutamyltransferase Perhaps one of the most controversial aspects concerning y-glutamyltransferase activity is its association with hepatic damage and enzyme induction by alcohol. Long term excessive consumption of alcohol not only causes liver damage and disease but may also lead to increased serum y-glutamyltransferase activity, either by direct damage to the liver cell or by the induction of microsomal enzymes in the absence of overt damage. Serum y-glutamyltransferase values may be exceedingly high in alcoholics, but the precise mechanism for the rise, as for that found in epileptics taking anticonvulsants, is still not clear. 43 The finding that a raised serum y-glutamyltransferase activity may be the only detectable abnormality25 41 44 46 48 Thus quite a large proportion of alcoholics do not have a raised serum y-glutamyltransferase activity,5 49 and the tendency for it to decrease to normal values in alcoholics of long standing has also been reported. 48 Assessment of y-glutamyltransferase activity has also been used to detect occult alcoholism in a healthy population undergoing general medical screening. 51 The reason for including measurement of y-glutamyltransferase activity as a screening test for alcoholism was probably based on its apparent relation to alcohol consumption. These early studies had reported that serum y-glutamyltransferase activity was raised in a large proportion of alcoholic patients. Nevertheless, the relatively low prevalence of alcoholism in the general population together with the few controls monitored in the first trials gave a false impression of the value of serum y-glutamyltransferase activity as a screening test. If we assume that the prevalence of alcoholism in the British population is about 1 /o52 and that the sensitivity and specificity of y-glutamyltransferase activity for detecting alcoholism is 75% and 97 5'0 respectively, then the predictive value of a positive result is about 20'(/o. This means that in the absence of any other abnormality out of 10 patients with a raised serum y-glutamyltransferase activity, only two will have been caused by alcohol, other factors being responsible for the raised values in the other patients. If the prevalence of alcoholism in a population is higher then the predictive value of a positive result will be correspondingly increased. With this type of calculation the definition of an "alcoholic" becomes very subjective, but clearly a person should never be classed as an excessive drinker of alcohol solely on the basis of a raised serum y-glutamyltransferase activity. The social stigma attached to alcoholism and the effect on job prospects must never be forgotten. The diagnosis should not be made without very good evidence, and possibly the only reliable evidence is a consistently raised blood alcohol concentration. Several recent articles have reported apparently healthy people with raised y-glutamyltransferase values, even though their alcohol intake would not be considered excessive.'0 54 For these reasons, y-glutamyltransferase estimations are losing favour for indicating excessive alcohol intake.
In more specific investigations of alcohol abuse y-glutamyltransferase has been claimed to be a useful enzyme to measure. It has been used to provide evidence if excessive drinking is suspected but denied by the patient,55 to verify abstinence when used in conjunction with aspartate transaminase measurements,56 to detect hepatic disease in suspected alcoholics,5 and to monitor progress and abstention by serial measurements.57 58 Even here, however, though some workers have found y-glutamyltransferase measurement useful as an indicator of continuing alcohol consumption,57 others have been unable to correlate estimations of y-glutamyltransferase with alcohol intake. 59 It has been suggested that y-glutamyltransferase measurement may be of greater diagnostic value when combined with other markers of alcohol intake, such as serum concentrations of urate and triglycerides and erythrocyte mean corpuscular volume.54 60 61 Raised concentrations of urate and triglyceride, however, although perhaps slightly more common in alcoholics, are also common in non-alcoholic subjects. y-Glutamyltransferase may rise to about five times the upper reference limit in acute pancreatitis with smaller rises in the chronic disease. 3 3 The highest activities have been observed in carcinoma of the head of the pancreas. In pancreatic disease, however, the finding of a raised serum y-glutamyltransferase activity must be interpreted with caution as it may be neither diagnostic nor specific to the pancreas. The raised y-glutamyltransferase activity may reflect concomitant hepatic damage in alcohol associated pancreatitis or pancreatitis after biliary obstruction.
CARDIAC DISEASE
There have been many reports of increased y-glutamyltransferase values after myocardial infarction"'' even though the y-glutamyltransferase content of cardiac tissue is very low.
Opinion varies as to the mechanism of the increase in y-glutamyltransferase activity, but it is generally thought to be due to tissue repair in the damaged areas of the myocardium, to hypoxic damage to the liver, or to enzyme induction in response to concomitant drug treatment. The pattern of rise and fall of y-glutamyltransferase activity during myocardial infarction appears to be inconsistent and consequently measuring yglutamyltransferase activity has no advantage over creatine kinase, aspartate transaminase, or lactate dehydrogenase assays. False positives may also occur in congestive cardiac failure, in which the liver is the most likely source of the increase in y-glutamyltransferase activity. In angina y-glutamyltransferase activity has been claimed to be of some diagnostic use since it has been reported to be the only biochemical abnormality in 65%0 of cases, although the source of the enzyme is obscure.33 The problem of poor specificity remains.
RENAL DISEASE
Although kidney tissue has a very high content of y-glutamyltransferase activity, high serum activities of the enzyme are not common in renal disorders. Slightly raised activities may be found in acute renal failure, nephrotic syndrome, and posttransplant rejection, but they are of uncertain origin and not diagnostically useful.' NEUROLOGICAL DISORDERS Raised y-glutamyltransferase activity in serum has been reported in cases of cerebral tumour and cerebrovascular accident.64 A group of epileptic subjects was also included in this particular study, and it was considered that the increase in serum y-glutamyltransferase values reflected changes in the vascular endothelium during necrotic or repair processes. The results displayed no apparent relation to drug administration. Most of the patients studied were having continuous drug treatment, however, and possibly hepatic microsomal enzyme induction of y-glutamyltransferase by anticonvulsants or hepatotoxicity after drug treatment is the most likely explanation. DIABETES 
MELLITUS
Up to 57"/, of diabetics, especially those with vascular complications, have raised y-glutamyltransferase activities.25 26 36 Such rises occur in the absence of liver disease, and the possibility of enzyme induction was put forward after a study of a group of serum enzyme values, such as alkaline phosphatase and glucose 6-phosphatase, with increased activity in some diabetic patients.3 Like y-glutamyltransferase these enzymes are associated with hepatic microsomes and may share a common mechanism of induction. The effects of carbohydrate metabolism on enzyme induction must also be considered.65 Estimation of y-glutamyltransferase activity in these patients at present serves no useful clinical function.
MISCELLANEOUS y-Glutamyltransferase activity may occasionally rise in chronic obstructive pulmonary disease,66 in patients with cervical cancer after radiotherapy,67 and in the fortnight after severe trauma.66
Conclusions
In the face of the widely varying factors that influence serum --glutamyltransferase values, it is hardly surprising that glutamyltransferase estimations have not lost popularity for differential diagnosis among clinicians, even though it is one of the most sensitive indicators of hepatobiliary disease. The considerable overlap of values in many diseases coupled with the influence of so many variables on the serum enzyme activity reinforce the recent doubts that have been expressed about the clinical value of the test. Refinements to the reference ranges for serum y-glutamyltransferase activity, together with the inclusion of serum y-glutamyltransferase values in some discriminant function models may provide a small improvement in diagnostic value.69°Examination of the multiple forms of y-glutamyltransferase activity may also yield some information about the tissue of origin of the serum activity, although methods for their characterisation have not been reliably established.31 1
It is doubtful if determination of serum total y-glutamyltransferase activity should retain a place in the diagnostic repertoire, although a case might be made for its use in children with suspected biliary tract disease. In most cases the serum transaminase activity remains the best indicator of mild hepatocellular damage and blood alcohol concentrations of alcoholism. It seems an appropriate time for laboratories performing yglutamyltransferase estimations to re-examine the requests for this test and assess whether the results are clinically useful.
